205 related articles for article (PubMed ID: 29324814)
1. Comprehensive molecular profiling of advanced/metastatic olfactory neuroblastomas.
Topcagic J; Feldman R; Ghazalpour A; Swensen J; Gatalica Z; Vranic S
PLoS One; 2018; 13(1):e0191244. PubMed ID: 29324814
[TBL] [Abstract][Full Text] [Related]
2. Comprehensive Molecular Profiling of Olfactory Neuroblastoma Identifies Potentially Targetable
Lazo de la Vega L; McHugh JB; Cani AK; Kunder K; Walocko FM; Liu CJ; Hovelson DH; Robinson D; Chinnaiyan AM; Tomlins SA; Harms PW
Mol Cancer Res; 2017 Nov; 15(11):1551-1557. PubMed ID: 28775129
[TBL] [Abstract][Full Text] [Related]
3. Relationship of p53 gene alterations with tumor progression and recurrence in olfactory neuroblastoma.
Papadaki H; Kounelis S; Kapadia SB; Bakker A; Swalsky PA; Finkelstein SD
Am J Surg Pathol; 1996 Jun; 20(6):715-21. PubMed ID: 8651351
[TBL] [Abstract][Full Text] [Related]
4. Recurrent Wnt Pathway and ARID1A Alterations in Sinonasal Olfactory Carcinoma.
Rooper LM; Agaimy A; Bell D; Gagan J; Gallia GL; Jo VY; Lewis JS; London NR; Nishino M; Stoehr R; Thompson LDR; Din NU; Wenig BM; Westra WH; Bishop JA
Mod Pathol; 2024 May; 37(5):100448. PubMed ID: 38369189
[TBL] [Abstract][Full Text] [Related]
5. Paired tumor and normal whole genome sequencing of metastatic olfactory neuroblastoma.
Weiss GJ; Liang WS; Izatt T; Arora S; Cherni I; Raju RN; Hostetter G; Kurdoglu A; Christoforides A; Sinari S; Baker AS; Metpally R; Tembe WD; Phillips L; Von Hoff DD; Craig DW; Carpten JD
PLoS One; 2012; 7(5):e37029. PubMed ID: 22649506
[TBL] [Abstract][Full Text] [Related]
6. Genetic and molecular alterations in olfactory neuroblastoma: implications for pathogenesis, prognosis and treatment.
Czapiewski P; Kunc M; Haybaeck J
Oncotarget; 2016 Aug; 7(32):52584-52596. PubMed ID: 27256979
[TBL] [Abstract][Full Text] [Related]
7. Recurrent Olfactory Neuroblastoma Treated With Cetuximab and Sunitinib: A Case Report.
Wang L; Ding Y; Wei L; Zhao D; Wang R; Zhang Y; Gu X; Wang Z
Medicine (Baltimore); 2016 May; 95(18):e3536. PubMed ID: 27149458
[TBL] [Abstract][Full Text] [Related]
8. Comprehensive Genomic Profiling of Esthesioneuroblastoma Reveals Additional Treatment Options.
Gay LM; Kim S; Fedorchak K; Kundranda M; Odia Y; Nangia C; Battiste J; Colon-Otero G; Powell S; Russell J; Elvin JA; Vergilio JA; Suh J; Ali SM; Stephens PJ; Miller VA; Ross JS
Oncologist; 2017 Jul; 22(7):834-842. PubMed ID: 28495808
[TBL] [Abstract][Full Text] [Related]
9. Expression of the human Achaete-scute 1 gene in olfactory neuroblastoma (esthesioneuroblastoma).
Carney ME; O'Reilly RC; Sholevar B; Buiakova OI; Lowry LD; Keane WM; Margolis FL; Rothstein JL
J Neurooncol; 1995 Oct; 26(1):35-43. PubMed ID: 8583243
[TBL] [Abstract][Full Text] [Related]
10. Targeted 595-gene genomic profiling demonstrates low tumor mutational burden in olfactory neuroblastoma.
Friedman J; Schumacher JK; Papagiannopoulos P; Al-Khudari S; Tajudeen BA; Batra PS
Int Forum Allergy Rhinol; 2021 Jan; 11(1):58-64. PubMed ID: 32558242
[TBL] [Abstract][Full Text] [Related]
11. Odorant receptor genes are expressed in olfactory neuroblastoma.
Gonzalez-Kristeller DC; Gutiyama LM; Campos AH; Soares FA; Brentani H; Malnic B
Genet Mol Res; 2013 Sep; 12(3):3479-87. PubMed ID: 24065686
[TBL] [Abstract][Full Text] [Related]
12. Olfactory neuroblastoma: the long-term outcome and late toxicity of multimodal therapy including radiotherapy based on treatment planning using computed tomography.
Mori T; Onimaru R; Onodera S; Tsuchiya K; Yasuda K; Hatakeyama H; Kobayashi H; Terasaka S; Homma A; Shirato H
Radiat Oncol; 2015 Apr; 10():88. PubMed ID: 25888953
[TBL] [Abstract][Full Text] [Related]
13. Multiplatform molecular profiling identifies potentially targetable biomarkers in malignant phyllodes tumors of the breast.
Gatalica Z; Vranic S; Ghazalpour A; Xiu J; Ocal IT; McGill J; Bender RP; Discianno E; Schlum A; Sanati S; Palazzo J; Reddy S; Pockaj B
Oncotarget; 2016 Jan; 7(2):1707-16. PubMed ID: 26625196
[TBL] [Abstract][Full Text] [Related]
14. [Clinicopathologic study of sinonasal teratocarcinosarcoma and its contrast with olfactory neuroblastoma].
Li X; Liu HG; Xie XJ; Han YD; Li M
Zhonghua Bing Li Xue Za Zhi; 2008 Jul; 37(7):458-64. PubMed ID: 19035117
[TBL] [Abstract][Full Text] [Related]
15. Frequent expression of somatostatin receptor 2a in olfactory neuroblastomas: a new and distinctive feature.
Czapiewski P; Kunc M; Gorczyński A; Haybaeck J; Okoń K; Reszec J; Lewczuk A; Dzierzanowski J; Karczewska J; Biernat W; Turri-Zanoni M; Castelnuovo P; Taverna C; Franchi A; La Rosa S; Sessa F; Klöppel G
Hum Pathol; 2018 Sep; 79():144-150. PubMed ID: 29807052
[TBL] [Abstract][Full Text] [Related]
16. Expression of Bcl-2 in olfactory neuroblastoma and its association with chemotherapy and survival.
Kim JW; Kong IG; Lee CH; Kim DY; Rhee CS; Min YG; Kim CW; Chung JH
Otolaryngol Head Neck Surg; 2008 Nov; 139(5):708-12. PubMed ID: 18984268
[TBL] [Abstract][Full Text] [Related]
17. Transcription Factor Expression in Sinonasal Neuroendocrine Neoplasms and Olfactory Neuroblastoma (ONB): Hyams' Grades 1-3 ONBs Expand the Spectrum of SATB2 and GATA3-Positive Neoplasms.
Uccella S; Facco C; Chiaravalli AM; Pettenon F; La Rosa S; Turri-Zanoni M; Castelnuovo P; Cerati M; Sessa F
Endocr Pathol; 2022 Jun; 33(2):264-273. PubMed ID: 35522392
[TBL] [Abstract][Full Text] [Related]
18. [Cytogenetic aberrations of esthesioneuroblastoma studied by comparative genomic hybridization].
You XJ; Petersen I; Arps H; Draf W; Bockmühl U
Zhonghua Zhong Liu Za Zhi; 2005 Jan; 27(1):16-21. PubMed ID: 15771791
[TBL] [Abstract][Full Text] [Related]
19. Expression pattern of ISL-1, TTF-1 and PAX5 in olfactory neuroblastoma.
Czapiewski P; Gorczyński A; Haybaeck J; Okoń K; Reszeć J; Skrzypczak W; Dzierżanowski J; Kunc M; Karczewska J; Biernat W
Pol J Pathol; 2016 Jun; 67(2):130-5. PubMed ID: 27543867
[TBL] [Abstract][Full Text] [Related]
20. Appendix-derived Pseudomyxoma Peritonei (PMP): Molecular Profiling Toward Treatment of a Rare Malignancy.
Gleeson EM; Feldman R; Mapow BL; Mackovick LT; Ward KM; Morano WF; Rubin RR; Bowne WB
Am J Clin Oncol; 2018 Aug; 41(8):777-783. PubMed ID: 28263231
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]